The overall goal for this 5-year research project is to explore the ramifications of our initial discovery: Neurotransmitter-receptor stimulation influences processing of the amyloid beta-protein precursor (APP). The proposed experiments all revolve around this common theme and are designed to clarify mechanisms of APP processing. In order to accomplish this goal, we will conduct experiments using cell culture and brain slice systems. There are 4 specific aims.
In aim #1, we will determine the effects of receptor activation on APP metabolism and synthesis. Individual experiments will explore the effects of receptor activation on APP endosomal-lysosomal processing, APP cleavage, APP gene expression, and translation rates; whether receptor activation also changes the secretion of other transmembrane proteins such as APLP1, APLP2, and TGF-alpha; and whether receptor-mediated APP secretion protects cells from excitotoxic damage.
In aim #2, we will determine whether receptor stimulation blocks Abeta secretion. We will also determine whether receptor stimulation blocks the abnormally high Abeta secretion caused by the APP mutations in the Swedish FAD kindred, and whether other FAD- associated APP mutations suppress receptor-activated APP processing.
In aim #3 m we will explore additional cell surface receptors for their effects on APP processing and we will examine receptor chimeras to characterize the signal transduction pathways that mediate APP processing.
In aim #4, we will examine receptor-mediated regulation of APP processing in mammalian brain. Using an in vitro rat brain slice preparation, we will study the conditions in which neuronal activity influences APP processing in brain as opposed to cell cultures. In particular, we will determine which specific neurotransmitter receptor systems mediate APP cleavage and secretion of soluble Abeta in mammalian brain. These experiments rely upon expertise that we have developed over the past 3 years and extend our initial observations regarding the effects of neurotransmitter receptor activation on APP processing. Successful achievement of these 4 specific aims will delineate mechanisms of APP processing and identify sites for potential therapeutic intervention at which APP metabolism may be altered.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005134-11
Application #
3745728
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Wegmann, Susanne; Eftekharzadeh, Bahareh; Tepper, Katharina et al. (2018) Tau protein liquid-liquid phase separation can initiate tau aggregation. EMBO J 37:
Racine, Annie M; Brickhouse, Michael; Wolk, David A et al. (2018) The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment. Alzheimers Dement (Amst) 10:301-310
Bennett, Rachel E; Robbins, Ashley B; Hu, Miwei et al. (2018) Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease. Proc Natl Acad Sci U S A 115:E1289-E1298
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Lee, Catherine; Betensky, Rebecca A; Alzheimer's Disease Neuroimaging Initiative (2018) Time-to-event data with time-varying biomarkers measured only at study entry, with applications to Alzheimer's disease. Stat Med 37:914-932
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416

Showing the most recent 10 out of 966 publications